Q&A: WebMD Chief David Schlanger
David Schlanger became WebMD’s CEO in August of 2013, but first joined the company in 1995, after serving as executive director, business development at Merck.
David Schlanger became WebMD’s CEO in August of 2013, but first joined the company in 1995, after serving as executive director, business development at Merck.
The commercialization of pharmaceutical drugs has changed a lot in two decades: industry’s focus on specialty drugs for smaller populations and patients with chronic disease has supplanted the emphasis on big name primary care products, and the blanket TV buys that propelled them into blockbuster glory.
David Schlanger
Schlanger says he chuckles when he sees Abbvie’s TV ad pushing Humira for Crohn’s disease-”there’s only 2 million people with Crohn’s disease” in the US-because it stands as a relic of a bygone era where the biggest media spend all but guaranteed the largest chunk of the market. Money still talks, of course, but fewer patients are all tuned in to the same listening apparatus. Physicians and patients still need to be educated about prescription drugs, but with limited access to the former, and a larger cost burden placed on the latter, drug companies hoping to reach their target audiences (and target sales revenues) do better by concentrating on the quality of interaction, not the quantity of exposure.
For Pharm Exec’s Q&A with David Schlanger, click here.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
